Boron-loaded liposomes in the treatment of hepatic metastases: Preliminary investigation by autoradiography analysis

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 7, Issue 2, 2000, Pages 97-103

  Pavanetto, Franca ^a   Perugini, Paola ^a,d   Genta, Ida ^a   Minoia, Claudio ^b   Ronchi, Anna ^b   Prati, Ubaldo ^c   Roveda, Laura ^c   Nano, Rosanna ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b IRCCS   (Italy)

^c Immunohematology and Transfusion Center   (Italy)

^d NONE   (Italy)

Author keywords

Antitumor Therapy; Boron Neutron Capture Therapy (BNCT); Boronophenylalanine; Liposomes

Indexed keywords

BORON; CHOLESTEROL; LIPOSOME; PHENYLALANINE DERIVATIVE; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TISSUE LEVEL; LIPID BILAYER; LIVER METASTASIS; MASS SPECTROMETRY; MEMBRANE VESICLE; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL;

EID: 0034125950     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/107175400266669     Document Type: Article

References (15)

1. Altieri, S., Braghieri, A., Fossati, F., Pedroni, P., Pinelli, T., Perotti, A., Specchiarello, M., Perlini, G., Rief, H., Chiaraviglio, D., De Grazia, F., and Zonta, A. 1989. Evaluation of a selective boron absorption in liver tumors. Strahlentherapie und Onkologie 165:170-172.
2. Barth, R. F., Soloway, A. H., and Brugger, R. M. 1996. Boron neutron capture therapy of brain tumors: past history, current status, and future potential. Cancer Invest. 14:534-550.
3. Earth, R. F., Soloway, A. H., and Fairchild, R. G. 1992. Boron neutron capture therapy for cancer. Cancer 70:2995-3007.
4. Chen, W., Mehta, S. C., and Lu, D. R. 1997. Selective boron drug delivery to brain tumors for boron neutron capture therapy. Adv. Drug Del. Rev. 26:231-247.
5. Gabizon, A., and Papahadjopoulos, D. 1988. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Nat. Acad. Sci. USA 85:6949-6953.
6. Hawthorne, M. F. 1993. The role of chemistry in the development of boron neutron capture therapy of cancer. Angewandte Chemie Inter. Ed. in English 32:950-984.
7. Hawthorne, M. F., and Shelly, K. 1997. Liposomes as drug delivery vehicles for boron agents. J. Neuro-oncol. 33:53-58.
8. Liu, D. 1996. Animal species dependent liposome clearance. J. Liposome Res. 6:77-97.
9. Mallesch, J. L., Hons, B., Moore, D. E., Alien, B. J., McCarthy, W. H., Jones, R., and Stening, W. A. 1994. The pharmacokinetics of p-boronophenylalanine fructose in human patients with glioma and metastatic melanoma. Int. J. Rad. Onc. Biol. Phys. 28:1183-1188.
10. Mehta, S. C., Lai, J. C. K., and Lu, D. R. 1996. Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy. J. Microencapsulation 13:269-279.
11. Mori, Y., Suzuki, A., Yoshino, K., and Kakihana, H. 1989. Complex formation of p-boronophenylalanine with some monosaccharides. Pigment Cell Res. 2:273-277.
12. Perugini, P., and Pavanetto, F. 1998. Liposomes containing boronophenylalanine for boron neutron capture therapy. J. Microencapsulation 15:473-483.
13. Pinelli, T., Altieri, S., Fossati, F., Zonta, A., Cossard, D., Prati, U., Roveda, L., Ricevuti, G., and Nano, R. 1996. Development of a method to use boron neutron capture therapy for diffused tumours of liver (Taormina project). In Cancer neutron capture therapy, ed. Mishima, 783-794. New York: Plenum Press.
14. Poste, G. 1986. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies. Cancer Treat. Rep. 70:183-199.
15. Uchiyama, K., Nagayasu, A., Yamagiwa, Y., Nishida, T., Harashima, H., and Kiwada, H. 1995. Effects of the size and fluidity of liposomes on their accumulation in tumours: a presumption of their interaction with tumours. Int. J. Pharm. 121:195-203.